Prenatal genetic analysis of fetal aberrant right subclavian artery with or without additional ultrasound anomalies in a third level referral center
Authors:
Open Access
- 28 February 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Abstract
To evaluate the correlation between chromosomal abnormalities and fetal aberrant right subclavian artery (ARSA) with or without additional ultrasound anomalies (UAs). A total of 340 fetuses diagnosed with ARSA by ultrasound between December, 2015, and July, 2021, were included. All cases were subdivided into three groups: (A) 121 (35.6%) cases with isolated ARSA, (B) 91 (26.8%) cases with soft markers, and (C) 128 (37.6%) cases complicated with other UAs. Invasive testing was performed via amniotic fluid or cord blood karyotyping and chromosomal microarray analysis (CMA) in parallel, and pregnancy outcomes were followed. Karyotype abnormalities were identified in 18/340 (5.3%) patients. Karyotype abnormalities in Groups A, B, and C were 0/121 (0.0%), 7/91 (7.7%), and 11/128 (8.6%), respectively. CMA abnormalities with clinically significant variants were detected in 37/340 (10.9%) cases, of which 22q11.2 deletion syndrome and trisomy 21 accounted for 48.6% (18/37). The overall abnormal CMA with clinically significant variant detection rates in Groups A, B, and C were 3/121(2.5%), 13/91 (14.3%), and 21/128 (16.4%), respectively. There were significant difference in clinically significant CMA anomalies detection rate between Groups A and C (p < 0.05), as well as Groups A and B (p < 0.05). Comparing CMA to karyotyping showed a clinically significant incremental yield in Group C (7.8%, 10/128) compared to Groups A (2.5%, 3/121) and B (6.6%, 6/91) (p > 0.05). Fetal ARSA with additional UAs, concurred with cardiac and extra-cardiac anomalies, constitutes a high-risk factor for chromosomal aberrations, especially for pathogenic or likely pathogenic copy number variants.Keywords
Funding Information
- the Joint Funds for the innovation of science and Technology,Fujian province (2020Y9149)
- 2021 Fujian provincial health technology project (2021GGA051)
- Natural Science Foundation of Fujian Province (2022J01421)
This publication has 51 references indexed in Scilit:
- Aberrant right subclavian artery (ARSA) in unselected population at first and second trimester ultrasonographyPrenatal Diagnosis, 2012
- Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second‐trimester fetusesUltrasound in Obstetrics & Gynecology, 2011
- Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormalityUltrasound in Obstetrics & Gynecology, 2010
- Gastrointestinal: Dysphagia lusoriaJournal of Gastroenterology and Hepatology, 2008
- Frequency of Aberrant Subclavian Artery, Arch Laterality, and Associated Intracardiac Anomalies Detected by EchocardiographyThe American Journal of Cardiology, 2008
- Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetusesUltrasound in Obstetrics & Gynecology, 2007
- Aortic Development and AnomaliesSeminars in Interventional Radiology, 2007
- Basics of Cardiac Development for the Understanding of Congenital Heart MalformationsPediatric Research, 2005
- Fetal sonographic diagnosis of aortic arch anomaliesUltrasound in Obstetrics & Gynecology, 2003
- Development of the human heart: days 15–21Heart, 2002